Cannabis Law Report

AUGUST 9, 2021

Disclaimer for Forward-Looking Information. cannabis beverage company Keef Brands. This news release contains forward-looking statements.

Events 105

Events Retail Therapy Cannabis 105

Cannabis Law Report

AUGUST 11, 2021

Disclaimer for Forward-Looking Information. cannabis beverage company Keef Brands. On behalf of the Board of Directors: John Campbell, Chief Financial Officer and Chief Strategy Officer. Director, BevCanna Enterprises Inc. This news release contains forward-looking statements.

Research and Development 105

Research and Development Retail Events Media 105

Cannabis Law Report

AUGUST 10, 2021

Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

Supply Chain 98

Supply Chain Patients Consumption Events 98

Cannabis Law Report

AUGUST 10, 2021

The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments.

Collective 105

Collective Hydroponic Events Business 105

Cannabis Law Report

AUGUST 12, 2021

Except as required by law, COMPASS disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 9, 2021

Disclaimer. Readers are cautioned not to put undue reliance on forward-looking statements, and Merida and Leafly assume no obligation and, except as required by law, do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Business 105

Business Retail Events Environment 105

Cannabis Law Report

AUGUST 10, 2021

Forward-looking statements speak only as of the date they are made and MyMD disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Contact: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105